Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Fish Shellfish Immunol ; 93: 500-507, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31377430

ABSTRACT

A feeding trial was conducted to evaluate the effects of different molar mass chitooligosaccharides (1000 Da, 3000 Da and 8000 Da) on growth, antioxidant capacity, non-specific immune response, and resistance to Aeromonas hydrophila in GIFT tilapia (Oreochromis niloticus). A total of 600 fish were divided into four treatments with five replicates of thirty fish per tank. The results showed that the supplementation of 1000 Da and 3000 Da COS significantly improved the growth performance and feed utilization in GIFT tilapia. The trend of decreasing total cholesterol, triglyceride, ALT, and ACP activity was observed in fish fed diet supplemented COS. The supplementation of 1000 Da and 3000 Da COS significantly improved the serum TAC activity, and decreased the serum MDA and catalase activities (P < 0.05). The lysozyme activity of blood, liver, and gills in fish fed diets supplemented with 1000 Da and 3000 Da COS was significantly higher than that of fish fed control diet after 56 days of feeding (P < 0.05). The phagocytic activity and phagocytic index of fish fed diets supplemented with 1000 Da and 3000 Da COS were significantly higher than those of fish fed control diet. Post-challenge test showed that fish mortality in 1000 Da, 3000 Da, and 8000 Da COS groups were significantly lower than that of fish in control group (P < 0.05). In conclusion, the present study indicated that dietary 1000 Da and 3000 Da COS supplementation could enhance more performance and immune response of GIFT tilapia than 8000 Da COS.


Subject(s)
Antioxidants/metabolism , Cichlids/immunology , Disease Resistance/drug effects , Fish Diseases/immunology , Immunity, Innate/drug effects , Oligosaccharides/metabolism , Aeromonas hydrophila/physiology , Animal Feed/analysis , Animals , Cichlids/growth & development , Diet/veterinary , Dietary Supplements/analysis , Disease Resistance/immunology , Dose-Response Relationship, Drug , Gram-Negative Bacterial Infections/immunology , Gram-Negative Bacterial Infections/veterinary , Immunity, Innate/immunology , Oligosaccharides/administration & dosage
2.
Fish Physiol Biochem ; 45(4): 1331-1342, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31011873

ABSTRACT

The aim of this work is to evaluate the effects of dietary inclusion of mixed plant protein (MP) (rapeseed meal:cottonseed meal:peanut meal = 1:1:1) on growth, body composition, blood biochemical parameters, growth hormone/insulin-like growth factor 1, and relative non-specific immune response in Yellow River carp Cyprinus carpio. Five isonitrogenous and isoenergetic trial diets were formulated to replace fish meal at 0 (MP0, control), 25% (MP25), 50% (MP50), 75% (MP75), and 100% (MP100) mixed plant protein, respectively. The 25% mixed plant protein did not affect the weight gain, specific growth rate, and protein efficiency ratio, whereas these parameters were depressed by 50% and above mixed plant protein. The whole body protein content gradually decreased with increasing dietary MP; meanwhile, the whole body lipid content is the opposite. The MP75 and MP100 diets adversely affected the glucose level, total cholesterol value, alanine transaminase, and aspartate transaminase activity of serum. Fish fed MP75 and MP100 diets showed higher growth hormone level than that of MP0 diet; however, the insulin-like growth factor 1 level got the opposite result. The 50% and above inclusion of MP decreased lysozyme activity and increased malondialdehyde content. In conclusion, no more than 50% of fish meal could be replaced by mixed plant protein in diet. However, 50% and above inclusion of mixed plant protein in diet could depress the growth, insulin-like growth factor 1 level, and non-specific immune response, and significantly affect the whole body composition and serum biochemical parameters in Yellow River carp.


Subject(s)
Animal Feed , Carps , Diet/veterinary , Plant Proteins/pharmacology , Animals , Carps/blood , Carps/growth & development , Carps/immunology , Fish Proteins/blood , Growth Hormone/blood , Insulin-Like Growth Factor I/analysis , Malondialdehyde/blood , Muramidase/blood , Superoxide Dismutase/blood
3.
Fish Physiol Biochem ; 44(5): 1265-1274, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29961187

ABSTRACT

A feeding trial was conducted to evaluate the effects of chromium picolinate (Cr-Pic) on growth performance, body composition, and biochemical parameters in Nile tilapia Oreochromis niloticus. Five experimental diets were formulated with high-protein diet (HP), low-protein diet (LP), and LP + 0.6, 1.2, or 1.8 mg kg-1 Cr, respectively. Each diet was randomly assigned to four replicate groups of 30 fish per aquarium in a water-circulated rearing system for 60 days. Dietary 1.2 or 1.8 mg kg-1 Cr inclusion significantly affects the final body weight, weight gain rate, specific growth rate, feed efficiency rate, and protein efficiency ratio of tilapia compare to the LP diet. The Cr inclusion significantly decreased the content of blood urea nitrogen and the blood glucose level generally with increasing Cr inclusion levels. The Cr content of gill tissue was higher than that of back muscle in all treatments, and the addition of 1.2 or 1.8 mg kg-1 Cr significantly enhanced the Cr contents of back muscle. The cold stress test results showed that adding Cr significantly enhanced the serum T3 concentration and reduced the activity of serum creatine kinase and the serum cortisol level. These results indicated that the supplementation of chromium picolinate can improve the growth performance and reshape the serum protein and carbohydrate metabolism profile and has the potentiality to alleviate the detrimental effects of cold stress in Nile tilapia. The low-protein diet with 1.8 mg kg-1 Cr obtained the same growth performance as the high-protein diet.


Subject(s)
Animal Feed/analysis , Body Composition/drug effects , Cichlids/growth & development , Dietary Supplements , Picolinic Acids/pharmacology , Animal Nutritional Physiological Phenomena , Animals , Aquaculture , Cichlids/blood , Diet/veterinary , Dose-Response Relationship, Drug , Picolinic Acids/administration & dosage
4.
Phytother Res ; 27(8): 1225-31, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23055269

ABSTRACT

Yerba Mate tea (Mate) is believed to be a natural source of cardioprotective lipid-lowering and antioxidant compounds. In this study, the antihyperlipidemic and antioxidant effects of Mate tea in a rat hyperlipidemia model were investigated. Male Sprague-Dawley rats were divided randomly into five groups and fed varying diets: standard diet, hyperlipidemic diet, and hyperlipidemic diet supplemented with low, moderate, or high concentrations of Mate tea aqueous extract (1%, 2%, and 4% w/v, respectively). Compared to the hyperlipidemic control group, Mate tea reduced significantly the total body weight and lowered serum levels of total cholesterol, triglyceride, and low-density lipoprotein-cholesterol, and caused the elevation of serum levels of high-density lipoprotein-cholesterol. Moreover, activities of superoxide dismutase and glutathione peroxidase in serum were elevated significantly, whereas the levels of malondialdehyde decreased. In addition, Mate tea treatment ameliorated significantly the severe fatty degeneration of liver cells that occurred in the hyperlipidemic groups. The relative levels of sterol regulatory element binding protein 1 and its target fatty acid synthase, as well as acetyl-CoA carboxylase mRNA transcripts were reduced, whereas peroxisome proliferator-activated receptor alpha mRNA transcripts were elevated in the Mate tea groups. Our results suggest that Mate tea exerts strong antioxidant and lipid-lowering effects, prevents hepatic fatty deposition, and regulates the expression of lipid metabolic regulators. It can therefore be used to reduce the risk of atherosclerosis.


Subject(s)
Antioxidants/pharmacology , Hyperlipidemias/drug therapy , Hypolipidemic Agents/pharmacology , Ilex paraguariensis/chemistry , Plant Extracts/pharmacology , Animals , Antioxidants/chemistry , Body Weight/drug effects , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Diet , Disease Models, Animal , Hypolipidemic Agents/chemistry , Liver/drug effects , Liver/metabolism , Male , Oxidative Stress/drug effects , PPAR alpha/metabolism , Plant Extracts/chemistry , Rats , Rats, Sprague-Dawley , Risk Factors , Sterol Regulatory Element Binding Protein 1/metabolism , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...